For new biotechnology firms with or without in-house statistical capabilities, we provide consultation on the design and analysis of Phase 1 through Phase 3 trials. Clients utilize our guidance and statistical expertise in preparing protocols for clinical trials. We consult with scientists and clinicians on the development of drugs— and as young companies grow, we help them find new staff statisticians.
One of our strengths is our vast experience in the statistical data monitoring of multicenter randomized clinical trials. We offer end-to-end management, collaboration, and guidance through a scientific lens to help clients define a study design and analyses that address the research hypotheses and lead to clear and comprehensive scientific conclusions.
Staff members conduct original research in statistics and have made significant contributions to the scientific literature. Our statisticians have applied both recently developed and conventional statistical methods to the wide range of study designs encountered in research and development in clinical trials and epidemiology.
To contact SCI about a potential project, please call us at 202.247.9700 or click below.
Statistics Collaborative is experencing a business interruption due to circumstances beyond our control. Please call our main company phone number for details and updates.